These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6784933)

  • 21. New antigens presented on tumor cells can cause immune rejection without influencing the frequency of tumor-specific cytolytic T cells.
    von Hoegen P; Altevogt P; Schirrmacher V
    Cell Immunol; 1987 Oct; 109(2):338-48. PubMed ID: 3117377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than immunosuppression.
    Uyttenhove C; Maryanski J; Boon T
    J Exp Med; 1983 Mar; 157(3):1040-52. PubMed ID: 6187879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of altered B7 expression in dioxin immunotoxicity: B7 transfection restores the CTL but not the autoantibody response to the P815 mastocytoma.
    Prell RA; Kerkvliet NI
    J Immunol; 1997 Mar; 158(6):2695-703. PubMed ID: 9058803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of P815 tumor immunity by recombinant Semliki Forest virus expressing the P1A gene.
    Colmenero P; Liljeström P; Jondal M
    Gene Ther; 1999 Oct; 6(10):1728-33. PubMed ID: 10516722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recurrent T cell receptor rearrangements in the cytotoxic T lymphocyte response in vivo against the p815 murine tumor.
    Levraud JP; Pannetier C; Langlade-Demoyen P; Brichard V; Kourilsky P
    J Exp Med; 1996 Feb; 183(2):439-49. PubMed ID: 8627157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody-induced redistribution of Heymann antigen on the surface of cultured glomerular visceral epithelial cells: possible role in the pathogenesis of Heymann glomerulonephritis.
    Camussi G; Brentjens JR; Noble B; Kerjaschki D; Malavasi F; Roholt OA; Farquhar MG; Andres G
    J Immunol; 1985 Oct; 135(4):2409-16. PubMed ID: 3875653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages.
    Kovacsovics-Bankowski M; Clark K; Benacerraf B; Rock KL
    Proc Natl Acad Sci U S A; 1993 Jun; 90(11):4942-6. PubMed ID: 8506338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytotoxic T cell responses to a syngeneic tumour: conditions for primary activation in vitro.
    Warren HS; Woolnough JA; Lafferty KJ
    Aust J Exp Biol Med Sci; 1978 Apr; 56(2):247-51. PubMed ID: 98140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of suppressor cells in mice bearing syngeneic mastocytoma.
    Takei F; Levy JG; Kilburn DG
    J Immunol; 1977 Feb; 118(2):412-7. PubMed ID: 65423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytochalasin-B-induced immunosuppression of murine allogeneic anti-tumor response and the effect of recombinant human interleukin-2.
    Bogyo D; Fondy SR; Finster L; Fondy C; Patil S; Fondy TP
    Cancer Immunol Immunother; 1991; 32(6):400-5. PubMed ID: 1901032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitation of intercellular binding strength by disruptive centrifugation: application to the analysis of adhesive interactions between P815 tumour cells and activated macrophages.
    Lepoivre M; Lemaire G
    Ann Inst Pasteur Immunol (1985); 1986; 137C(3):329-44. PubMed ID: 3090927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Individual differences in the orientation of the cytolytic T cell response against mouse tumor P815.
    Brichard VG; Warnier G; Van Pel A; Morlighem G; Lucas S; Boon T
    Eur J Immunol; 1995 Mar; 25(3):664-71. PubMed ID: 7705394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of interactions between the corneal epithelium and liposomes: qualitative and quantitative fluorescence studies of a corneal epithelial cell line.
    Pleyer U; Grammer J; Kosmidis P; Ruckert DG
    Surv Ophthalmol; 1995 May; 39 Suppl 1():S3-16. PubMed ID: 7660310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice.
    Van den Eynde B; Lethé B; Van Pel A; De Plaen E; Boon T
    J Exp Med; 1991 Jun; 173(6):1373-84. PubMed ID: 1903428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A retroviral peptide encoded by mutated env p15E gene is recognized by specific CD8+ T lymphocytes on drug-treated murine mastocytoma P815.
    Belladonna ML; Fioretti MC; Bianchi R; Puccetti P; Grohmann U
    Int J Immunopharmacol; 1996 Oct; 18(10):563-76. PubMed ID: 9080250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inflammation and cancer, the mastocytoma P815 tumor model revisited: triggering of macrophage activation in vivo with pro-tumorigenic consequences.
    Kamate C; Baloul S; Grootenboer S; Pessis E; Chevrot A; Tulliez M; Marchiol C; Viguier M; Fradelizi D
    Int J Cancer; 2002 Aug; 100(5):571-9. PubMed ID: 12124807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor cell surface expression of granulocyte-macrophage colony-stimulating factor elicits antitumor immunity and protects from tumor challenge in the P815 mouse mastocytoma tumor model.
    Soo Hoo W; Lundeen KA; Kohrumel JR; Pham NL; Brostoff SW; Bartholomew RM; Carlo DJ
    J Immunol; 1999 Jun; 162(12):7343-9. PubMed ID: 10358185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Solubilization of histocompatibility and tumour-associated antigens of the P-815 murine mastocytoma cell.
    Clemetson KJ; Gerber A; Bertschmann M; Lüscher EF
    Eur J Cancer (1965); 1976 Apr; 12(4):263-70. PubMed ID: 821757
    [No Abstract]   [Full Text] [Related]  

  • 39. Tumour-associated antigens of the mouse P-815 mastocytoma cell: evidence for an antigen with H-2-like characteristics.
    Clemetson KJ; Bertschmann M; Lüscher EF
    Mol Immunol; 1981 Feb; 18(2):135-41. PubMed ID: 6167852
    [No Abstract]   [Full Text] [Related]  

  • 40. CD8+ cell activation to a major mastocytoma rejection antigen, P815AB: requirement for tum- or helper peptides in priming for skin test reactivity to a P815AB-related peptide.
    Grohmann U; Bianchi R; Fioretti MC; Fallarino F; Binaglia L; Uyttenhove C; Van Pel A; Boon T; Puccetti P
    Eur J Immunol; 1995 Oct; 25(10):2797-802. PubMed ID: 7589074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.